These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31044094)

  • 1. DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease.
    Dussold C; Gerber C; White S; Wang X; Qi L; Francis C; Capella M; Courbon G; Wang J; Li C; Feng JQ; Isakova T; Wolf M; David V; Martin A
    Bone Res; 2019; 7():12. PubMed ID: 31044094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone and heart health in chronic kidney disease: role of dentin matrix protein 1.
    Martin A
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):297-303. PubMed ID: 31107286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of DMP1 in CKD-MBD.
    Martin A; Kentrup D
    Curr Osteoporos Rep; 2021 Oct; 19(5):500-509. PubMed ID: 34331667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease.
    Courbon G; Francis C; Gerber C; Neuburg S; Wang X; Lynch E; Isakova T; Babitt JL; Wolf M; Martin A; David V
    Bone Res; 2021 Aug; 9(1):35. PubMed ID: 34334787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic background influences cardiac phenotype in murine chronic kidney disease.
    Neuburg S; Dussold C; Gerber C; Wang X; Francis C; Qi L; David V; Wolf M; Martin A
    Nephrol Dial Transplant; 2018 Jul; 33(7):1129-1137. PubMed ID: 29309658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Francis C; Courbon G; Gerber C; Neuburg S; Wang X; Dussold C; Capella M; Qi L; Isakova T; Mehta R; Martin A; Wolf M; David V
    Kidney Int; 2019 Dec; 96(6):1346-1358. PubMed ID: 31668632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy.
    Pereira RC; Salusky IB; Roschger P; Klaushofer K; Yadin O; Freymiller EG; Bowen R; Delany AM; Fratzl-Zelman N; Wesseling-Perry K
    Kidney Int; 2018 Nov; 94(5):1002-1012. PubMed ID: 30348285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice.
    Andrukhova O; Schüler C; Bergow C; Petric A; Erben RG
    Front Endocrinol (Lausanne); 2018; 9():311. PubMed ID: 29942284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice.
    Leifheit-Nestler M; Wagner MA; Richter B; Piepert C; Eitner F; Böckmann I; Vogt I; Grund A; Hille SS; Foinquinos A; Zimmer K; Thum T; Müller OJ; Haffner D
    Front Cell Dev Biol; 2021; 9():745892. PubMed ID: 34778257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model.
    Nagata Y; Imanishi Y; Ohara M; Maeda-Tateishi T; Miyaoka D; Hayashi N; Kurajoh M; Emoto M; Inaba M
    Endocrinology; 2019 May; 160(5):1348-1358. PubMed ID: 30916761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
    Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
    Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
    J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23.
    Yan L; Bowman MA
    Inflamm Cell Signal; 2014; 1(5):. PubMed ID: 26082935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mutation in the Dmp1 Gene Alters Phosphate Responsiveness in Mice.
    Ichikawa S; Gerard-O'Riley RL; Acton D; McQueen AK; Strobel IE; Witcher PC; Feng JQ; Econs MJ
    Endocrinology; 2017 Mar; 158(3):470-476. PubMed ID: 28005411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
    Pereira RC; Juppner H; Azucena-Serrano CE; Yadin O; Salusky IB; Wesseling-Perry K
    Bone; 2009 Dec; 45(6):1161-8. PubMed ID: 19679205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD.
    Liesen MP; Noonan ML; Ni P; Agoro R; Hum JM; Clinkenbeard EL; Damrath JG; Wallace JM; Swallow EA; Allen MR; White KE
    Physiol Rep; 2022 Jun; 10(11):e15307. PubMed ID: 35656701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 induces left ventricular hypertrophy.
    Faul C; Amaral AP; Oskouei B; Hu MC; Sloan A; Isakova T; Gutiérrez OM; Aguillon-Prada R; Lincoln J; Hare JM; Mundel P; Morales A; Scialla J; Fischer M; Soliman EZ; Chen J; Go AS; Rosas SE; Nessel L; Townsend RR; Feldman HI; St John Sutton M; Ojo A; Gadegbeku C; Di Marco GS; Reuter S; Kentrup D; Tiemann K; Brand M; Hill JA; Moe OW; Kuro-O M; Kusek JW; Keane MG; Wolf M
    J Clin Invest; 2011 Nov; 121(11):4393-408. PubMed ID: 21985788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteocyte-specific dentin matrix protein 1 : the role of mineralization regulation in low-magnitude high-frequency vibration enhanced osteoporotic fracture healing.
    Li MCM; Chow SK; Wong RMY; Chen B; Cheng JCY; Qin L; Cheung WH
    Bone Joint Res; 2022 Jul; 11(7):465-476. PubMed ID: 35787000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.